Suppr超能文献

接受药物治疗或手术治疗的左主干冠状动脉疾病患者的预后:一项倾向匹配分析。

Outcomes of patients with left main coronary artery disease undergoing medical or surgical treatment: a propensity-matched analysis.

作者信息

De Lorenzo Andrea, Tura Bernardo, Bassan Fernando, Pittella Felipe, Rocha Antonio Sergio C

机构信息

National Institute of Cardiology, Rio de Janeiro, Brazil.

出版信息

Coron Artery Dis. 2011 Dec;22(8):585-9. doi: 10.1097/MCA.0b013e32834c7501.

Abstract

OBJECTIVE

To evaluate the outcomes of patients with significant (≥ 50%) left main coronary artery disease (LMCAD) undergoing medical treatment (MT) or coronary artery bypass grafting surgery (CABG).

METHODS

A total of 181 patients with significant LMCAD were followed for 4 ± 2 years. MT was done when patients refused CABG or because of either thin native vessels or high clinical risk. Events were defined as all-cause death, myocardial infarction, percutaneous coronary intervention, or subsequent CABG. Logistic regression analysis was used to identify independent predictors of death. A propensity score was created to compare outcomes of patients from the two treatment groups.

RESULTS

CABG was performed in 78.5% of the patients. Overall, there were no significant differences in the incidences of death or other events between treatment groups. In patients with normal left ventricular (LV) function (ejection fraction, ≥ 45%), there were no significant differences in event rates with MT or CABG (death, 7.7 vs. 12.1%; myocardial infarction, 0 vs. 1.9%; percutaneous coronary intervention, 3.8 vs. 5.6%). For patients with LV dysfunction, death was more frequent with MT than with CABG (53.8 vs. 22.9%, P<0.001), whereas the incidence of other events was not statistically different. Age and LV dysfunction, but not treatment type, were independent predictors of death. When comparing propensity-matched patients from both treatment groups, there was also no difference in survival.

CONCLUSION

Patients with 50% or more LMCAD and LV dysfunction had increased survival with CABG. However, outcomes of patients with 50% or more LMCAD and normal LV function were not significantly different with either MT or CABG.

摘要

目的

评估患有严重(≥50%)左主干冠状动脉疾病(LMCAD)的患者接受药物治疗(MT)或冠状动脉旁路移植术(CABG)的治疗结果。

方法

共对181例患有严重LMCAD的患者进行了4±2年的随访。当患者拒绝CABG或由于自身血管纤细或临床风险高而进行MT。事件定义为全因死亡、心肌梗死、经皮冠状动脉介入治疗或随后的CABG。采用逻辑回归分析确定死亡的独立预测因素。创建倾向评分以比较两个治疗组患者的治疗结果。

结果

78.5%的患者接受了CABG。总体而言,治疗组之间的死亡或其他事件发生率无显著差异。在左心室(LV)功能正常(射血分数≥45%)的患者中,MT或CABG的事件发生率无显著差异(死亡,7.7%对12.1%;心肌梗死,0对1.9%;经皮冠状动脉介入治疗,3.8%对5.6%)。对于LV功能不全的患者,MT组的死亡频率高于CABG组(53.8%对22.9%,P<0.001),而其他事件的发生率无统计学差异。年龄和LV功能不全是死亡的独立预测因素,而非治疗类型。比较两个治疗组倾向匹配的患者时,生存率也没有差异。

结论

LMCAD 50%及以上且LV功能不全的患者接受CABG可提高生存率。然而,LMCAD 50%及以上且LV功能正常的患者,MT或CABG的治疗结果无显著差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验